4588 fundamentals

Oncolys BioPharma, Inc. engages in the research and development of cancer treatment therapy and diagnostics which include early detection, loco-regional therapy, prognostic test, and systemic treatments. It operates through the Pharmaceutical and Diagnostics segments. The Pharmaceutical segment deals with the research, development, manufacture, and sale of pharmaceutical products. The Diagnostics segment engages in the research, development, manufacture, and sale of test agents and equipment as well as the provision of testing services. The company was founded by Yasuo Urata on March 18, 2004 and is headquartered in Tokyo, Japan.